1. bookVolume 18 (2017): Edizione 2 (June 2017)
Dettagli della rivista
Prima pubblicazione
30 Mar 2016
Frequenza di pubblicazione
4 volte all'anno
access type Accesso libero

Hiponatremia in the practice of a psychiatrist. Part 2: psychogenic polydipsia

Pubblicato online: 01 Sep 2017
Volume & Edizione: Volume 18 (2017) - Edizione 2 (June 2017)
Pagine: 138 - 152
Ricevuto: 08 Mar 2017
Accettato: 31 May 2017
Dettagli della rivista
Prima pubblicazione
30 Mar 2016
Frequenza di pubblicazione
4 volte all'anno

Objective. The study is the second part of the literature review on hyponatremia in patients with diagnosed mental disorders. This article focuses on psychogenic polydipsia as, along with the SIADH, one of the two most common causes of hyponatremia in the mentioned group of patients.

Method: The literature review was based on searching the Medline, the Google Scholar and the Ebsco databases in Polish and English by entering the following phrases: psychogenic polydipsia, the psychosis – intermittent hyponatremia – polydipsia syndrome, water intoxication.

Discussion: Psychogenic polydipsia occurs in up to 25% of patients treated for mental disorders. It most frequently concerns patients with schizophrenia. 30% of patients with psychogenic polydipsia suffer from hyponatremia with or without symptoms of water intoxication. In the etiology of psychogenic polydipsia, the influence of dopaminergic and noradrenergic neurotransmission has been considered, as well as angiotensin, which is claimed to have dipsogenic properties. In order to reduce the severity of the disorder, attempts have been made to administer the following groups of medications: β-blockers, opioid receptor antagonists, angiotensin convertase inhibitors and angiotensin receptor antagonists. Other methods include replacing classic antipsychotic drugs with clozapine. There are also reports of a reduced severity of polydipsia with hyponatremia after introducing risperidone and olanzapine. Preventing episodes of water intoxication in patients with psychogenic polydipsia requires the monitoring of their body weight and a suitable reduction of fluid intake by them.

Results: Mentally ill patients, especially those with chronic schizophrenia, should be monitored for psychogenic polydipsia and the concomitant hyponatremia.


1. de Leon J, Verghese C, Tracy JI, Josiassen RC, Simpson GM. Polydipsia and water intoxication in psychiatric patients: a review of the epidemiological literature. Biol Psychiatry 1994;35(6):408-419.10.1016/0006-3223(94)90008-6Search in Google Scholar

2. Verghese C, De Leon J, Simpson GM. Neuroendocrine factors influencing polydipsia in psychiatric patients: an hypothesis. Neuropsychopharmacology.1993;9(2):157-166.10.1038/npp.1993.54Search in Google Scholar

3. Mercier-Guidez, Loas G. Polydipsia and water intoxication in 353 psychiatric inpatients: an epidemiological and psychopathological study. Eur Psychiatry. 2000;15(5):306-311.10.1016/S0924-9338(00)00399-0Search in Google Scholar

4. de Leon J. Polydipsia-a study in a long-term psychiatric unit. Eur Arch Psychiatry Clin Neurosci. 2003 :253(1):37-39.10.1007/s00406-003-0403-zSearch in Google Scholar

5. Iftene F, Bowie C, Milev R, Hawken E, Talikowska-Szymczak E, Potopsingh D, Hanna S, Mulroy J, Groll D, Millson R. Identification of primary polydipsia in a severe and persistent mental illness outpatient population: a prospective observational study. Psychiatry Res.2013;210(3):679-683.10.1016/j.psychres.2013.04.011Search in Google Scholar

6. Williams ST, Kores RC. Psychogenic polydipsia: comparison of a community sample with an institutionalized population. Psychiatry Res. 2011;187(1-2):310-31110.1016/j.psychres.2010.10.035Search in Google Scholar

7. Peh LH, Devan GS, Eu P Water intoxication in psychiatric patients in Singapore. Singapore Med J 1990: 31(3):238-241Search in Google Scholar

8. Naito M, Ito K, Funayama S, Inoue M. The Influence of Subjective Oral Dryness and Salivary Volume on Polydipsia in Patients with Schizophrenia. International Journal of Oral-Medical Sciences.2013;12(1):29-34.10.5466/ijoms.12.29Search in Google Scholar

9. Goldman MB. The mechanism of life-threatening water imbalance in schizophrenia and its relationship to the underlying psychiatric illness. Brain Res Rev. 2009; 61(2), 210-220.10.1016/j.brainresrev.2009.06.004Search in Google Scholar

10. Vieweg WVR, David JJ, Rowe WT, Wampler GJ, Burns WJ, Spradlin WW. Death from self-induced water intoxication among patients with schizophrenic disorders. J Nerv Ment Dis. 1985;173(3):161-165.10.1097/00005053-198503000-00005Search in Google Scholar

11. Loas G, Mercier-Guidez E. Fatal self-induced water intoxication among schizophrenic inpatients. Eur Psychiatry. 2002; 17(6):307-310.10.1016/S0924-9338(02)00687-9Search in Google Scholar

12. Hawken ER, Crookall JM, Reddick D, Millson RC, Milev R, Delva. Mortality over a 20-year period in patients with primary polydipsia associated with schizophrenia: a retrospective study. Schizophr Res. 2009;107(2):128-133.10.1016/j.schres.2008.09.029Search in Google Scholar

13. Reynolds S A, Schmid MW, Broome ME. Polydipsia screening tool. Arch Psychiatr Nurs.2004;18(2):49-59.10.1053/j.apnu.2004.01.003Search in Google Scholar

14. Abbasi QA, Carbonell FE, Koczapski AB, Vieweg WV R. Measuring and estimating daily urine volume in psychiatric patients: strengths and weaknesses. Schizophr Res. 1997:28(1):87-93.10.1016/S0920-9964(97)00086-8Search in Google Scholar

15. Goldman MB. The assessment and treatment of water imbalance in patients with psychosis. Clin Schizophr Relat Psychoses. 2010;4(2):115-23.10.3371/CSRP.4.2.3Search in Google Scholar

16. Krzyżanowska-Świniarska B, Czekalski S. Choroby układu podwzgórzowo-przysadkowego. W. Interna .Tom3 red Januszewicz K, Kokot F. Wydawnictwo Lekarskie PZWL. Warszawa 2004Search in Google Scholar

17. Zilles D, Hasan A, Gruber O, Degner D. Acute polydipsia and water intoxication in first episode schizophrenia. Aust N Z J Psychiatry. 2010;44(5):489-489.10.3109/00048671003614163Search in Google Scholar

18. Verbalis JG, Goldsmith SR, Greenberg A, Schrier RW, Sterns RH. Hyponatremia treatment guidelines 2007: expert panel recommendations. Am J Med 2007;120(11):1-21.10.1016/j.amjmed.2007.09.001Search in Google Scholar

19. Chen LC, Bai YM., Chang MH. Polydipsia, hyponatremia and rhabdomyolysis in schizophrenia: A case report. World J Psychiatry.2014; 4(4):150-152.10.5498/wjp.v4.i4.150Search in Google Scholar

20. Blum A, Tempey, FW, Lynch WJ. Somatic findings in patients with psychogenic polydipsia. J Clin Psychiatry.1983;44(2):55-56Search in Google Scholar

21. Blum A, Friedland GW. (1983). Urinary tract abnormalities due to chronic psychogenic polydipsia. Am J Psychiatry.1983;140(7):915-916.Search in Google Scholar

22. Delva NJ, Crammer JL, Jarzylo SV, Lawson JS, Owen JA, Sribney M, Weir BJ, Yendt ER. Osteopenia, pathological fractures, and increased urinary calcium excretion in schizophrenic patients with polydipsia. Biol Psychiatry. 1989;26(8):781-93.10.1016/0006-3223(89)90119-4Search in Google Scholar

23. Bralet MC, Ton T, Falissard B. Schizophrenic patients with polydipsia and water intoxication more often have a form of schizophrenia first described by Kraepelin. Psychiatry Res. 2007:152(2), 267-271.Search in Google Scholar

24. Kirch DG, Bigelow LB, Weinberger DR, Lawson WB, Wyatt R J. Polydipsia and chronic hyponatremia in schizophrenic inpatients. J Clin Psychiatry 1985;46(5):179-181.Search in Google Scholar

25. Ripley TL, Millson R C, Koczapski AB. Self-induced water intoxication and alcohol abuse. Am J Psychiatry.1989;146(1):102-103.10.1176/ajp.146.1.1022912229Search in Google Scholar

26. Poirier S, Legris G, Tremblay P, Michea R, Viau-Guay L, Mérette C, Roy M A. Schizophrenia patients with polydipsia and water intoxication are characterized by greater severity of psychotic illness and a more frequent history of alcohol abuse. Schizophr Res.2010;118(1):285-291.10.1016/j.schres.2009.12.03620096540Search in Google Scholar

27. Schnur DB, Wirkowsk E, Reddy R, Decina P, Mukherjee S. Cognitive impairments in schizophrenic patients with hyponatremia. Biol Psychiatry. 1993;33(11):836-838.10.1016/0006-3223(93)90025-9Search in Google Scholar

28. Emsley RA, Spangenberg JJ, Roberts MC, Taljaard FJ, Chalton DO. Disordered water homeostasis and cognitive impairment in schizophrenia. Biol Psychiatry.1993;34(9):630-633.10.1016/0006-3223(93)90155-7Search in Google Scholar

29. Nagashima T, Inoue M, Kitamura S, Kiuchi K, Kosaka J, Okada K, Kishimoto T. Brain structural changes and neuropsychological impairments in male polydipsic schizophrenia. BMC Psychiatry 2012: 12(1), 210.10.1186/1471-244X-12-210Search in Google Scholar

30. Millson RC, Koczapski AB, Cook MI, Daszkiewicz M. A survey of patient attitudes toward self-induced water intoxication. Can J Psychiatry. 1992;37(1):46-7.10.1177/070674379203700110Search in Google Scholar

31. May DL. Patient perceptions of self-induced water intoxication. Arch Psychiatr Nurs. 1995;9(5):295-304.10.1016/S0883-9417(95)80049-2Search in Google Scholar

32. Nishikawa T, Tsuda A, Tanaka M, Nishikawa M, Koga I, Uchida Y. Involvement of the endogenous opioid system in the drinking behavior of schizophrenic patients displaying self-induced water intoxication: a double-blind controlled study with naloxone. Clin Neuropharmacol. 1996;19(3):252-258.10.1097/00002826-199619030-00007Search in Google Scholar

33. Nishikawa T, Tsuda A, Tanaka M, Nishikawa M, Koga I, Uchida Y. Naloxone attenuates drinking behavior in psychiatric patients displaying self-induced water intoxication. Prog Neuropsychopharmacol Biol Psychiatry.1994;18(1):149-53.10.1016/0278-5846(94)90031-0Search in Google Scholar

34. Shen WW, Sata LS.. Hypothalamic dopamine receptor supersensitivity? A pilot study of self-induced water intoxication. Psychiatr J Univ Ott. 1984;8(3):154-158.Search in Google Scholar

35. Shinkai T, Ohmori O, Hori H, Nakamura J. Genetic approaches to polydipsia in schizophrenia: A preliminary report of a family study and an association study of an angiotensin-converting enzyme gene polymorphism. Am J Med Genet Part B: Neuropsychiatr Genet. 2003;119(1):7-12.10.1002/ajmg.b.1006612707930Search in Google Scholar

36. Matsumoto C, Shinkai T, De Luca V, Hwang R, Hori H, Lanktree M, Nakamura J. Association between three functional polymorphisms of the dopamine D2 receptor gene and polydipsia in schizophrenia. Int J Neuropsychopharmacol.2005;8(2):245-253.10.1017/S146114570400490015850500Search in Google Scholar

37. Ouyang WC, Wang YC, Hong CJ, Cheng CY, Tsai SJ. Association study of angiotensin-converting enzyme gene polymorphism with schizophrenia and polydipsia. Neuropsychobiology. 2001;44(1):31-35.10.1159/00005491111408790Search in Google Scholar

38. Yamada K, Shinkai T, Chen HI, Utsunomiya K, Nakamura J. Effect of COMT Val108/158Met Genotype on Risk for Polydipsia in Chronic Patients with Schizophrenia. Neuromolecular Med. 2014;16(2):398-404.10.1007/s12017-014-8287-9Search in Google Scholar

39. Fukunaka Y, Shinkai T, Hwang R, Hori H, Utsunomiya K, Sakata S, Nakamura J. The orexin 1 receptor (HCRTR1) gene as a susceptibility gene contributing to polydipsia-hyponatremia in schizophrenia. Neuromolecular Med. 2007;9(4):292-297.10.1007/s12017-007-8001-2Search in Google Scholar

40. Shinkai T, De Luca V, Utsunomiya K, Sakata S, Inoue Y, Fukunaka Y, Nakamura J. Functional polymorphism of the human multidrug resistance gene (MDR1) and polydipsia–hyponatremia in Schizophrenia. Neuromolecular Med.2008;10(4):362-36710.1007/s12017-008-8041-2Search in Google Scholar

41. Goldman MB. The mechanism of life-threatening water imbalance in schizophrenia and its relationship to the underlying psychiatric illness. Brain Res Rev.2009;61(2):210-220.10.1016/j.brainresrev.2009.06.004Search in Google Scholar

42. Goldman MB, Robertson GL, Luchins DJ, Hedeker D, Pandey GN. Psychotic exacerbations and enhanced vasopressin secretion in schizophrenic patients with hyponatremia and polydipsia. Arch Gen Psychiatry.1997;54(5):443-449.10.1001/archpsyc.1997.01830170069010Search in Google Scholar

43. Goldman MB, Blake L, Marks RC, Hedeker D, Luchins D J. Association of nonsuppression of cortisol on the DST with primary polydipsia in chronic schizophrenia. Am J Psychiatry.1993;150(4) 653-653.10.1176/ajp.150.4.653Search in Google Scholar

44. Goldman MB, Gnerlich J, Hussain N. Neuroendocrine responses to a cold pressor stimulus in polydipsic hyponatremic and in matched schizophrenic patients. Neuropsychopharmacology. 2007; 32(7): 1611-1621.10.1038/sj.npp.1301282Search in Google Scholar

45. Goldman MB, Wang L, Wachi C, Daudi S, Csernansky J, Marlow-O’Connor M, Torres I. Structural pathology underlying neuroendocrine dysfunction in schizophrenia. Behav Brain Res.2011:218(1):106-113.10.1016/j.bbr.2010.11.025Search in Google Scholar

46. Thomas JL, Howe J, Gaudet A, Brantley PJ. Behavioral treatment of chronic psychogenic polydipsia with hyponatremia: a unique case of polydipsia in a primary care patient with intractable hiccups. J Behav Ther Exp Psychiatry.2001;32(4):241-250.10.1016/S0005-7916(02)00007-1Search in Google Scholar

47. Goldman MB, Luchins DJ. Prevention of episodic water intoxication with target weight procedure. Am J Psychiatry. 1987;144(3):365-36610.1176/ajp.144.3.3653826439Search in Google Scholar

48. Hayashi T, Nishikawa T, Koga I, Uchida Y, Horiguchi J, Yamawaki Involvement of the α2-adrenergic system in polydipsia in schizophrenic patients: a pilot study. Psychopharmacology.1997;130(4):382-386.10.1007/s002130050254Search in Google Scholar

49. Kishi Y, Kurosawa H, Endo S. Is propranolol effective in primary polydipsia? Int J Psychiatry Med.1998;28(3):315-325.10.2190/QPWL-14H7-HPGG-A29DSearch in Google Scholar

50. Gibson CAM, Stewart JT. Treatment of psychogenic polydipsia with pindolol. J Clin Psychopharmacol.2006;26(1):99-100.10.1097/01.jcp.0000195909.29117.b0Search in Google Scholar

51. Greendyke RM, Bernhardt AJ, Tasbas HE, Lewandowski KS. Polydipsia in chronic psychiatric patients: therapeutic trials of clonidine and enalapril. Neuropsychopharmacology. 1998;18(4):272-281.10.1016/S0893-133X(97)00159-0Search in Google Scholar

52. Tueth MJ, Broderick-Cantwell J. Successful treatment with captopril of an elderly man with polydipsia and hyponatremia. Journal of geriatric psychiatry and neurology.1993;6(2):112-114.10.1177/089198879300600209Search in Google Scholar

53. Goldstein JA. Captopril in the treatment of psychogenic polydipsia. J Clin Psychiatry.1986;47(2):99Search in Google Scholar

54. Sebastian CS, Sinha D, Gulati NK. Serum sodium stabilizing effect of enalapril after standard water load in a patient with a history of self-induced water intoxication. Prog Neuropsychopharmacol Biol Psychiatry.1995;19(4):655-663.10.1016/0278-5846(95)00109-9Search in Google Scholar

55. Kruse D, Pantelis C, Rudd R, Quek J, Herbert P, McKinley M. Treatment of psychogenic polydipsia: comparison of risperidone and olanzapine, and the effects of an adjunctive angiotensin-II receptor blocking drug (irbesartan). Aust N Z J Psychiatry.2001;35(1):65-68.10.1046/j.1440-1614.2001.00847.xSearch in Google Scholar

56. Webber MA, Ofalabi I, Mahmud W, Herron MS, Shekhar A. Losartan for treatment of psychogenic polydipsia. Ann Pharmacother. 2004;38(10):1750-1751.10.1345/aph.1D523Search in Google Scholar

57. Dong HS, Kim SH, Park SY. A Case Report: Irbesartan and Naltrexone Treatment of Polydipsia in a Patient with Schizophrenia. Korean J Schizophr Res.2015;18(2):86-90.10.16946/kjsr.2015.18.2.86Search in Google Scholar

58. Vieweg WVR, Weiss NM, David JJ, Rowe WT, Godleski L S, Spradlin WW. Treatment of psychosis, intermittent hyponatremia, and polydipsia (PIP syndrome) using lithium and phenytoin. Biol Psychiatry. 1988;23(1):25-30.10.1016/0006-3223(88)90103-5Search in Google Scholar

59. Vieweg WV, Wilkinson EC, David JJ, Rowe WT, Hobbs WB, Spradlin WW. The use of demeclocycline in the treatment of patients with psychosis, intermittent hyponatremia, and polydipsia (PIP syndrome). Psychiatr Q. 1988;59(1):62-68.10.1007/BF01064293Search in Google Scholar

60. Alexander RC, Karp BI, Thompson S, Khot V, Kirch DG. A double blind, placebo-controlled trial of demeclocycline treatment of polydipsia-hyponatremia in chronically psychotic patients. Biol Psychiatry. 1991;30(4):417-420.10.1016/0006-3223(91)90300-BSearch in Google Scholar

61. Josiassen RC, Goldman M, Jessani M, Shaughnessy RA, Albazzaz A, Lee J, Ouyang J, Orlandi C, Czerwiec F. Double-blind, placebo-controlled, multicenter trial of a vasopressin V2-receptor antagonist in patients with schizophrenia and hyponatremia. Biol Psychiatry. 2008:4(12):1097-1100.10.1016/j.biopsych.2008.06.01718692175Search in Google Scholar

62. Takagi S, Watanabe Y, Imaoka T, Sakata M, Watanabe M. Treatment of psychogenic polydipsia with acetazolamide: a report of 5 cases. Clin Neuropharmacol. 2011;34(1):5-710.1097/WNF.0b013e318205070b21242740Search in Google Scholar

63. Spears NM, Leadbetter RA, Shutty MS Jr. Clozapine treatment in polydipsia and intermittent hyponatremia. J Clin Psychiatry. 1996;57(3):123-8.Search in Google Scholar

64. Canuso CM, Goldman, MB. Clozapine restores water balance in schizophrenic patients with polydipsia-hyponatremia syndrome. J Neuropsychiatry Clin Neurosci.1999;11(1):86-90.10.1176/jnp.11.1.869990561Search in Google Scholar

65. Fuller MA, Jurjus G, Kwon K, Konicki PE, Jaskiw GE. Clozapine reduces water-drinking behavior in schizophrenic patients with polydipsia. J Clin Psychopharmacol. 1996;16(4):329-3210.1097/00004714-199608000-000108835710Search in Google Scholar

66. Margetić B, Aukst-Margetić B. Successful treatment of polydipsia, water intoxication, and delusional jealousy in an alcohol dependent patient with clozapine. Prog Neuro-Psychopharmacol Biol Psychiatry.2006;30(7):1347-1349.10.1016/j.pnpbp.2006.03.00516600455Search in Google Scholar

67. Tényi T, Vörös V. Successful switch to olanzapine after rhabdomyolysis caused by water intoxication and clozapine use. Pharmacopsychiatry.2006;39(4):157-158.10.1055/s-2006-94670816871473Search in Google Scholar

68. Chhoumi M, Mrad A, Mechri A. Risperidone treatment for polydipsia and severe hyponatremia in a schizophrenic patient. The rapie.2015;70(3):309-310.Search in Google Scholar

69. Rao N, Venkatasubramanian G, Korpade V, Behere R, Varambally S, Gangadhar, B. Risperidone treatment for polydipsia and hyponatremia in schizophrenia: a case report. Turk Psikiyatri Derg.2011;22(2):123-125.Search in Google Scholar

70. Kawai N, Baba A, Suzuki T. Risperidone failed to improve polydipsia-hyponatremia of the schizophrenic patients. Psychiatry Clin Neurosci.2002;56(1):107-110.10.1046/j.1440-1819.2002.00937.x11929579Search in Google Scholar

71. Millson RC, Emes CE, Glackman WG. Self-induced water intoxication treated with risperidone. Can J Psychiatry.1996;41(10):648-650.10.1177/0706743796041010088978944Search in Google Scholar

72. Ranga GS, Tomar LR, Narang S, Tripathi P, Jirwal OP. Risperidone causing hyponatremia. J Acute Med.2014;4(3):133-134.10.1016/j.jacme.2014.03.004Search in Google Scholar

73. Tenyi T, Vörös V. Successful switch to olanzapine after rhabdomyolysis caused by water intoxication and clozapine use. Pharmacopsychiatry.2006;39(04):157-158.10.1055/s-2006-94670816871473Search in Google Scholar

74. Goldman MB, Hussain N. Absence of effect of olanzapine on primary polydipsia: results of a double-blind, randomized study. Journal of clinical psychopharmacology. 2004;24(6):678-680.10.1097/01.jcp.0000145337.07676.2f15538138Search in Google Scholar

75. Spasovski G, Vanholder R, Allolio B i inni. Clinical practice guide-line on diagnosis and treatment of hyponatraemia. Eur J Endocrinol. 2014;170(3):1-47.10.1530/EJE-13-102024569125Search in Google Scholar

Articoli consigliati da Trend MD

Pianifica la tua conferenza remota con Sciendo